$ 18.62
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of KVUE is 21 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
